M
02181
Mabpharm
0.58
0.04+7.41%Opening09:56 12/02 HKT
OPEN/PREV CLOSE0.690/0.540
TODAY RANGE0.580-0.690
VOL32.00K
MARKET CAP2.39B
52 WEEK RANGE0.250-0.940
AVG VOL (3M)287.89K
% TURNOVER0.00%
TURNOVER20.96K
P/E (TTM)-79.452
% RANGE20.37%
EPS(TTM)-0.007
P/E(FORWARD)28.061
P/B22.053
BVPS0.026
DIVIDEND--
P/S5.146
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.39B
SHARES OUTSTANDING4.12B
NEXT EARNINGS--
FREE FLOAT4.12B
LOT SIZE2000
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·10/31 22:26
Mabpharm Limited's (HKG:2181) Low P/S No Reason For Excitement
Reuters·10/31 11:04
Mabpharm Appoints Lead Independent Director and Updates Nomination Committee
Reuters·10/31 11:04
Mabpharm Ltd. files director list with HKEX
Simply Wall St·09/29 22:06
Here's Why Mabpharm (HKG:2181) Can Afford Some Debt
Reuters·08/28 11:51
MABPHARM H1 REVENUE RMB 270 MILLION
Simply Wall St·07/28 23:47
Why Investors Shouldn't Be Surprised By Mabpharm Limited's (HKG:2181) Low P/S
Simply Wall St·06/11 22:03
We Think Some Shareholders May Hesitate To Increase Mabpharm Limited's (HKG:2181) CEO Compensation
Simply Wall St·06/02 22:21
Insiders were the key beneficiaries as Mabpharm Limited's (HKG:2181) market cap rises to HK$2.1b
Simply Wall St·04/26 00:33
Mabpharm Full Year 2024 Earnings: CN¥0.031 loss per share (vs CN¥0.051 loss in FY 2023)
Simply Wall St·03/27 23:42
Is Mabpharm (HKG:2181) Using Too Much Debt?
Reuters·03/26 12:56
MABPHARM FY GROSS PROFIT RMB 219.4 MILLION
Simply Wall St·02/05 23:46
Strong week for Mabpharm (HKG:2181) shareholders doesn't alleviate pain of five-year loss
Simply Wall St·12/22/2024 00:03
Investors Don't See Light At End Of Mabpharm Limited's (HKG:2181) Tunnel
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email : service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.